ATE359764T1 - Durch liposome vermittelte dna verabreichung - Google Patents

Durch liposome vermittelte dna verabreichung

Info

Publication number
ATE359764T1
ATE359764T1 AT02701476T AT02701476T ATE359764T1 AT E359764 T1 ATE359764 T1 AT E359764T1 AT 02701476 T AT02701476 T AT 02701476T AT 02701476 T AT02701476 T AT 02701476T AT E359764 T1 ATE359764 T1 AT E359764T1
Authority
AT
Austria
Prior art keywords
liposome
mediated dna
dna administration
host
administration
Prior art date
Application number
AT02701476T
Other languages
English (en)
Inventor
Moshe Baru
Original Assignee
Opperbas Holding Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Opperbas Holding Bv filed Critical Opperbas Holding Bv
Application granted granted Critical
Publication of ATE359764T1 publication Critical patent/ATE359764T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
AT02701476T 2001-02-22 2002-02-20 Durch liposome vermittelte dna verabreichung ATE359764T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27012101P 2001-02-22 2001-02-22

Publications (1)

Publication Number Publication Date
ATE359764T1 true ATE359764T1 (de) 2007-05-15

Family

ID=23029985

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02701476T ATE359764T1 (de) 2001-02-22 2002-02-20 Durch liposome vermittelte dna verabreichung

Country Status (5)

Country Link
US (1) US20040086558A1 (de)
EP (1) EP1361862B1 (de)
AT (1) ATE359764T1 (de)
DE (1) DE60219601T2 (de)
WO (1) WO2002066013A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030180348A1 (en) * 2002-03-22 2003-09-25 Levinson R. Saul Transcellular drug delivery system
AU2006291429B2 (en) * 2005-09-15 2013-04-04 Biontech Delivery Technologies Gmbh Improvements in or relating to amphoteric liposomes
JP5815915B2 (ja) * 2005-10-11 2015-11-17 ユニバーシティー オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケーション 過活動膀胱障害の治療のためのスフィンゴミエリンリポソーム

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2489769A1 (en) * 1989-03-21 1990-10-04 Philip L. Felgner Expression of exogenous polynucleotide sequences in a vertebrate
IL115199A (en) * 1995-09-07 2005-05-17 Opperbas Holding Bv Composition comprising a polynucleic acid molecule in a liposome and method using said composition
IL126681A0 (en) * 1998-10-21 1999-08-17 Opperbas Holding Bv Treatment of trauma-related conditions

Also Published As

Publication number Publication date
DE60219601T2 (de) 2007-12-27
WO2002066013A2 (en) 2002-08-29
US20040086558A1 (en) 2004-05-06
EP1361862B1 (de) 2007-04-18
WO2002066013A3 (en) 2002-11-21
EP1361862A2 (de) 2003-11-19
DE60219601D1 (de) 2007-05-31

Similar Documents

Publication Publication Date Title
ATE273320T1 (de) Fusogene liposomen
WO2004043363A3 (en) Protein-stabilized liposomal formulations of pharmaceutical agents
CY1113421T1 (el) Πυρηνικα οξεα και πολυπεπτιδια υποδοχεα
NO20001371L (no) Farmasøytiske preparater inneholdende plasmaprotein
IL233223A (en) Pharmaceutical and diagnostic compositions containing nucleic acids and corresponding proteins entitled 282p1g3
NL1015859A1 (nl) Farmaceutische preparaten.
NO20026255D0 (no) Polymere micelle sammensetninger
NO20033556D0 (no) Farmasöytiske preparater
NO992102D0 (no) Peptidblanding, samt farmasøytisk sammensetning og kreftvaksine som innbefatter peptidblandingen
ATE322255T1 (de) Polyamid-oligomere
ATE293169T1 (de) Latency associated peptide von tgf-beta um pharmazeutisch aktive proteine latent zu machen
DE60029219D1 (de) Verbesserte arzneizubereitungen enthaltend ritonavir
AU2001255260A1 (en) Macroaggregated protein conjugates as oral genetic immunization delivery agents
NO20025277L (no) Farmasoytisk administreringsform for peptider, dens fremstilling samt anvendelse
DE60142519D1 (de) Dna-expressionsvektoren
DE502004005560D1 (de) Pharmazeutische formulierungen enthaltend hochreine basen von 3,3-diphenylpropylaminmonoestern
IL164464A0 (en) Antagonists to mcp proteins, their preparation, pharmaceutical composition containing them, and their use
NO20026147L (no) Trombomodulinanaloger for farmasoytisk anvendelse
EP0979309A4 (de) Oligonukleotide mit verbesserter bioverfügbarkeit
ITMI982330A0 (it) Composizione farmaceutiche ad azione antitumorale contenente dna codificante per frammenti di una proteina antigenica
ATE359764T1 (de) Durch liposome vermittelte dna verabreichung
ATE345778T1 (de) (ester)-lysolecithine in liposomen
WO2001037780A8 (en) Urotensin-ii analogs
WO2002083840A3 (en) Compositions and methods for transepithelial transport of membrane-bounded vesicles and virions
AU2001292326A1 (en) Nucleic acid of novel human kinesin-associated gene, protein encoded by the nucleic acid, peptide fragment thereof and anticancer agents comprising the nucleic acid and the like

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties